Corcept Therapeutics Inc
CORT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001088856
In the last 90 days, Corcept Therapeutics Inc insiders filed 0 open-market purchases and 21 sales; 424 institutions reported holding it in 13F filings for Q2 2026, worth $7.15B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Corcept Therapeutics Inc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 285
- +13 vs. Q4 2023
- Shares held
- 93.8M
- +9.05M (+10.7%) vs. Q4 2023
- Total value
- $2.36B
- −$389.8M (−14.2%) vs. Q4 2023
- New holders
- 53
- 110 more added
- Sold out
- 40
- 89 more reduced
2 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CORT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 424 | $7.15B |
| Q1 2026 | 352 | $3.20B |
| Q4 2025 | 390 | $2.67B |
| Q3 2025 | 429 | $6.41B |
| Q2 2025 | 422 | $5.79B |
| Q1 2025 | 422 | $9.24B |
| Q4 2024 | 368 | $4.25B |
| Q3 2024 | 321 | $4.09B |
| Q2 2024 | 286 | $2.90B |
| Q1 2024 | 285 | $2.36B |
| Q4 2023 | 274 | $2.75B |
| Q3 2023 | 247 | $2.26B |
| Q2 2023 | 225 | $1.81B |
| Q1 2023 | 233 | $1.89B |
| Q4 2022 | 244 | $1.69B |
| Q3 2022 | 239 | $2.23B |
| Q2 2022 | 226 | $2.02B |
| Q1 2022 | 228 | $1.84B |
| Q4 2021 | 208 | $1.59B |
| Q3 2021 | 202 | $1.59B |
| Q2 2021 | 199 | $1.77B |
| Q1 2021 | 210 | $1.94B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Corcept Therapeutics Inc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Susquehanna Portfolio Strategies, LLC | 0 | $0 | 0.00% | −10,950−100.0% | Sold out |
| Atlas Capital Advisors LLC | 0 | $0 | 0.00% | −10,905−100.0% | Sold out |
| APG Asset Management N.V. | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −8,094−100.0% | Sold out |
| Diversified Trust Co | 0 | $0 | 0.00% | −7,656−100.0% | Sold out |
| Verity Asset Management, Inc. | 0 | $0 | 0.00% | −7,211−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −7,013−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −6,993−100.0% | Sold out |
| Evergreen Capital Management LLC | 0 | $0 | 0.00% | −6,651−100.0% | Sold out |
| Syon Capital LLC | 0 | $0 | 0.00% | −6,307−100.0% | Sold out |
| Cornerstone Investment Partners, LLC | 0 | $0 | 0.00% | −6,233−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −5,981−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −2,027−100.0% | Sold out |
| Planned Solutions, Inc. | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −1,178−100.0% | Sold out |
| Gladius Capital Management LP | 0 | $0 | 0.00% | −1,098−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Johnson Financial Group, Inc. | 0 | $0 | 0.00% | −608−100.0% | Sold out |
| Benjamin F. Edwards & Company, Inc. | 0 | $0 | 0.00% | −234−100.0% | Sold out |
| Arlington Trust Co LLC | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Carolinas Wealth Consulting LLC | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Rosenberg Matthew Hamilton | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Putnam Investments LLC | – | – | – | – | Not filed |
| Coppell Advisory Solutions LLC | – | – | – | – | Not filed |